On Wednesday, Teradyne (TER.US) surged more than 16%, reaching a record high of $167.28. The company reported better-than-expected Q3 results, with revenue of $769.2 million, surpassing the analyst consensus estimate of $743.776 million. Non-GAAP earnings per share stood at $0.85, exceeding the expected $0.79. Additionally, Teradyne provided robust Q4 guidance, projecting revenue between $920 million and $1 billion—a 25% sequential increase and 27% year-over-year growth—significantly outperforming analyst expectations.